NDC 31722-739 – Lamivudine and Zidovudine

Lamivudine 150 mg/1; Zidovudine 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC31722-739

Product details

Brand name
Lamivudine and Zidovudine
Generic name
Lamivudine and Zidovudine
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA203259
Marketed since
February 6, 2014
Listing expires
December 31, 2027
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for LAMIVUDINE and ZIDOVUDINE →

Package NDC codes (3)

Package NDCDescriptionSince
31722-739-05500 TABLET, FILM COATED in 1 BOTTLE (31722-739-05)Feb 6, 2014
31722-739-31100 TABLET, FILM COATED in 1 BLISTER PACK (31722-739-31)Feb 6, 2014
31722-739-6060 TABLET, FILM COATED in 1 BOTTLE (31722-739-60)Feb 6, 2014

Other LAMIVUDINE and ZIDOVUDINE products